Pfizer Gets OK On Drug For Rare Lung Disorder
May 29, 2015 at 06:52 AM EDT
Pfizer Inc. (NYSE: PFE) obtained regulatory approval Thursday to use its Rapamune drug as a treatment for a rare and often fatal lung ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.